Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 30-04 (MA.27) 

A randomized phase III trial of exemestane vs. anastrozole in postmenopausal women with receptor positive primary breast cancer

DESIGN

Please click on the picture to see a larger version

Results & Publications


Presentations

Study Chairs
IBCSG: Dr. Manuela Rabaglio - Bern, Switzerland
NCIC CTG: Dr. Paul Goss - Boston, USA

Trial Coordinator
Susanne Roux
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 81
Fax: +41 31 389 93 92
Email: ibcsg30-04_ma27@ibcsg.org

Date of Activation
April 12, 2005

Date of Closure
December 15, 2006

Targeted Accrual
6840 patients

Final Accrual
7459 patients


Results Publications Results & Publications
Other Pathology


News

11.12.2008:
BIG 1-98: Results from sequential treatment analysis and updated monotherapy analysis

11.12.2008:
Brinker Award for Richard Gelber and Aron Goldhirsch

11.12.2008:
All presentations from investigators' meetings at San Antonio Breast Cancer Symposium now

All News

 
  Print